Physician profile
David Neng
NPI 1437799491
$1,244.79
in general payments reported to CMS, 2019-2025
15 companies · $177 in 2025
The $177 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $133 · 2022: $146 · 2023: $535 · 2024: $254 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $966.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $966.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $577.29 | 2022-2025 | |
| Collegium Pharmaceutical, INC. | $258.52 | 2021-2023 | Belbuca, Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $65.48 | 2022-2023 | Relistor |
| Boston Scientific Corporation | $52.46 | 2021-2023 | |
| Merz Pharmaceuticals, LLC | $44.64 | 2022 | |
| Averitas Pharma INC. | $41.60 | 2024-2025 | Qutenza |
| Vertex Pharmaceuticals Incorporated | $36.37 | 2024-2025 | |
| Piramal Critical Care | $32.21 | 2022-2023 | |
| Biodelivery Sciences International, INC. | $30.84 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.90 | 2023 | |
| Spr Therapeutics, INC | $18.22 | 2025 | Sprint Pns System |
| Curonix LLC | $16.35 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Valinor Pharma, LLC | $16.16 | 2023 | Movantik |
| Medtronic, INC. | $14.83 | 2021 | |
| Biotronik Nro, INC. | $13.92 | 2025 | Prospera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Neng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.